F. Jarraya

2.0k total citations
45 papers, 613 citations indexed

About

F. Jarraya is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, F. Jarraya has authored 45 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in F. Jarraya's work include Dialysis and Renal Disease Management (10 papers), Blood Pressure and Hypertension Studies (7 papers) and Chronic Kidney Disease and Diabetes (6 papers). F. Jarraya is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Blood Pressure and Hypertension Studies (7 papers) and Chronic Kidney Disease and Diabetes (6 papers). F. Jarraya collaborates with scholars based in Tunisia, Belgium and Netherlands. F. Jarraya's co-authors include J. Hachicha, Kitty J. Jager, Pietro Ravani, Frédéric Collart, M. Kharrat, Friedo W. Dekker, Marlies Noordzij, Moniek W.M. van de Luijtgaarden, Patrik Finne and Johan De Meester and has published in prestigious journals such as Diabetologia, Gene and Journal of Thrombosis and Haemostasis.

In The Last Decade

F. Jarraya

41 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Jarraya Tunisia 13 267 109 79 73 69 45 613
Curtis Warfield United States 4 401 1.5× 121 1.1× 129 1.6× 52 0.7× 89 1.3× 5 813
Laura Cortés–Sanabria Mexico 14 326 1.2× 85 0.8× 84 1.1× 81 1.1× 80 1.2× 63 663
Adeera Levin Canada 10 386 1.4× 83 0.8× 62 0.8× 44 0.6× 114 1.7× 18 633
Anneke Kramer Netherlands 18 471 1.8× 94 0.9× 82 1.0× 59 0.8× 112 1.6× 46 784
Stephen McDonald Australia 16 313 1.2× 75 0.7× 56 0.7× 32 0.4× 71 1.0× 31 637
Boris Bikbov Italy 8 273 1.0× 67 0.6× 64 0.8× 170 2.3× 65 0.9× 17 678
Maya K. Rao United States 9 300 1.1× 77 0.7× 51 0.6× 54 0.7× 48 0.7× 15 645
Shahrzad Ossareh Iran 13 269 1.0× 106 1.0× 43 0.5× 58 0.8× 104 1.5× 55 564
Monica Beaulieu Canada 13 416 1.6× 100 0.9× 73 0.9× 60 0.8× 53 0.8× 26 648
Rajkumar Chinnadurai United Kingdom 13 203 0.8× 82 0.8× 54 0.7× 107 1.5× 41 0.6× 85 607

Countries citing papers authored by F. Jarraya

Since Specialization
Citations

This map shows the geographic impact of F. Jarraya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Jarraya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Jarraya more than expected).

Fields of papers citing papers by F. Jarraya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Jarraya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Jarraya. The network helps show where F. Jarraya may publish in the future.

Co-authorship network of co-authors of F. Jarraya

This figure shows the co-authorship network connecting the top 25 collaborators of F. Jarraya. A scholar is included among the top collaborators of F. Jarraya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Jarraya. F. Jarraya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jarraya, F., Abdou Niang, Elliot Koranteng Tannor, et al.. (2023). The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper. Kidney International Reports. 9(3). 526–548. 4 indexed citations
2.
Ariceta, Gema, Laure Collard, Saoussen Abroug, et al.. (2022). ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. Pediatric Nephrology. 38(2). 403–415. 13 indexed citations
3.
Jarraya, F., et al.. (2021). The inflammatory profile of chronic kidney disease patients. 5(3). 107–111. 1 indexed citations
4.
Hachicha, J., et al.. (2021). Primary membranoproliferative glomerulonephritis in Sfax, Tunisia: epidemiologic profile and prognostic factors. Pan African Medical Journal. 38. 218–218. 2 indexed citations
5.
Modesti, Pietro Amedeo, Ji‐Guang Wang, Albertino Damasceno, et al.. (2020). Indirect implications of COVID-19 prevention strategies on non-communicable diseases. BMC Medicine. 18(1). 256–256. 40 indexed citations
6.
Modesti, Pietro Amedeo, F. Jarraya, Gabriele Mascherini, & Francesco Perticone. (2020). Cardiometabolic risk prevention strategies: the importance of sharing experiences between Mediterranean countries. Internal and Emergency Medicine. 15(4). 543–548. 3 indexed citations
7.
8.
Yaïch, S., et al.. (2018). Profil épidémiologique de l'insuffisance rénale chronique terminale dans la région de Sfax. Pan African Medical Journal. 29. 64–64. 5 indexed citations
9.
10.
Jarraya, F.. (2016). Treatment of Hypertension: Which Goal for Which Patient?. Advances in experimental medicine and biology. 956. 117–127. 6 indexed citations
11.
Sayyari, Abdulla Al, et al.. (2016). Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study. Saudi Journal of Kidney Diseases and Transplantation. 27(2). 290–290. 7 indexed citations
12.
Luijtgaarden, Moniek W.M. van de, Marlies Noordzij, Pietro Ravani, et al.. (2013). Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia. 56(9). 1949–1957. 34 indexed citations
13.
Hachicha, J., et al.. (2013). Living and cadaver donor transplant programs in the maghreb. Saudi Journal of Kidney Diseases and Transplantation. 24(1). 150–150. 3 indexed citations
14.
Kanoun, Houda, et al.. (2013). A double mutation in AGXT gene in families with primary hyperoxaluria type 1. Gene. 531(2). 451–456. 6 indexed citations
15.
Jarraya, F., Menno Pruijm, Grégoire Wuerzner, & Michel Burnier. (2013). Blockade of the Renin-Angiotensin System in Hypertensive Patients with Atherosclerotic Renal Artery Stenosis. Current Hypertension Reports. 15(5). 497–505.
16.
Yaïch, S., et al.. (2012). Atypical Presentation of a Brown Tumor in a Kidney Transplant Recipient: A Case Report. Transplantation Proceedings. 44(9). 2849–2850. 2 indexed citations
17.
Yaïch, S., et al.. (2012). Sirolimus for the Treatment of Kaposi Sarcoma After Renal Transplantation: A Series of 10 Cases. Transplantation Proceedings. 44(9). 2824–2826. 26 indexed citations
18.
Carrero, Juan Jesús, Dinanda J. de Jager, Marion Verduijn, et al.. (2011). Cardiovascular and Noncardiovascular Mortality among Men and Women Starting Dialysis. Clinical Journal of the American Society of Nephrology. 6(7). 1722–1730. 110 indexed citations
19.
Kharrat, M., et al.. (2005). Infectious Complications in Kidney Transplant Recipients: A Single-Center Experience. Transplantation Proceedings. 37(6). 2823–2825. 41 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Curtis Warfield Breakdown of academic impact, for papers by Laura Cortés–Sanabria Breakdown of academic impact, for papers by Adeera Levin Breakdown of academic impact, for papers by Anneke Kramer Breakdown of academic impact, for papers by Stephen McDonald Breakdown of academic impact, for papers by Boris Bikbov Breakdown of academic impact, for papers by Maya K. Rao Breakdown of academic impact, for papers by Shahrzad Ossareh Breakdown of academic impact, for papers by Monica Beaulieu Breakdown of academic impact, for papers by Rajkumar Chinnadurai
Rankless by CCL
2026